Congress Materials - AAD Innovation Academy 2025
2025 AAD Innovation Academy | Jul 10-13 | Chicago, IL
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Treatment of Plaque Psoriasis Involving High-Impact Sites With Icotrokinra: Subgroup Analyses of the Phase 3, ICONIC-LEAD Trial
Jennifer Soung, H. Chih-Ho Hong, Benjamin Ehst, Dariusch Mortazawi, Megan Miller, Joseph Cafone, Gigi Jiang, Ya-Wen Yang, Robert Bissonette, Mark G. Lebwohl
This document will be available July 10th 2025
Unmet Needs of Adults with Psoriasis and Clinicians Treating Psoriasis in the US
Dr. Linda Stein Gold, Dr. Jennifer Soung, Laurie Conklin, Melina Taylor, Nina Trenkler, Jensen Lewis, Ashley Duenas, Gale Harding, Timothy Fitzgerald, Oluwakayode Adejoro, Ya-Wen Yang, Guo Li, Dr. Mona Shahriari
This document will be available July 10th 2025
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.